CD4 and central nervous system cancer: Regulatory T cells (Tregs) negatively regulate the immunoreaction, and previous evidence has demonstrated that the increased grade of glioma is proportional to the number of CD4+CD25+Foxop3 Treg cells in the peripheral blood of glioma patients, indicating that malignant progression of glioma might be associated with Treg immunosuppression (27, 28).